Intimation about Investment in Material Subsidiary
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures' material subsidiary, Time Medical International Ventures (India) Pvt Ltd, has acquired an additional 950 shares in Sascan Meditech Pvt Ltd for Rs. 2 crores in cash. This transaction adds 2.15% to its holding, bringing the cumulative stake to 16.74% of paid-up capital. Sascan Meditech, founded in 2015, develops healthcare devices and reported turnover of about Rs. 1 crore in its latest audited year. The deal, approved by Time Medical's board in July 2024, is described as a diversification and expansion move. It is not a related-party transaction and no regulatory approvals were needed.
The investment is small in scale and signals incremental portfolio expansion by the subsidiary rather than a transformative deal. For Fischer Medical Ventures shareholders, the impact on financials or stock price is likely minimal in the short term, though it reflects the group's continued push into healthcare devices.